Arecor Therapeutics (AREC)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

44.33p
   
  • Change Today:
      0.83p
  • 52 Week High: 159.00
  • 52 Week Low: 38.00
  • Currency: UK Pounds
  • Shares Issued: 37.76m
  • Volume: 33,257
  • Market Cap: £16.74m

AREC Overview

Arecor is a globally focused biopharmaceutical company that is targeting improving patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying the Group's innovative proprietary formulation technology platform, Arestat™, the Group is developing an internal portfolio of proprietary products, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of their partners' therapeutic products, supported by an extensive patent portfolio.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -211.7% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 3.3 n/a
Pr/Book 3.1  
Latest F'cast
Revenue 10.5% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

AREC Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 1.70 (3.51) (17.00)p n/a n/a n/a n/a 0.0%
31-Dec-21 1.16 (6.95) (27.00)p n/a n/a n/a n/a 0.0%
31-Dec-22 2.40 (10.54) (32.00)p n/a n/a n/a n/a 0.0%
31-Dec-23 4.57 (8.90) (0.28)p n/a n/a n/a n/a 0.0%
31-Dec-24 5.05 (10.62) (0.31)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

AREC Company Announcements

Result of AGM 02-Jun-2025 13:32 RNS
Non-Executive Director Board Change 02-Jun-2025 07:00 RNS
Director/PDMR Dealing 21-May-2025 07:00 RNS

Latest AREC Director Deals

Traded Action Notifier PriceAmountValue
19-May-25 Buy Sarah Jennifer Howell 46.97p 21,077 £9,899.87
19-May-25 Buy Andrew Richards 46.97p 31,750 £14,912.98
13-May-25 Buy Andrew Richards 41.25p 35,000 £14,437.50

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

AREC Market Data

Currency UK Pounds
Share Price 44.33p
Change Today 0.83p
% Change 1.92 %
52 Week High 159.00
52 Week Low 38.00
Volume 33,257
Shares Issued 37.76m
Market Cap £16.74m

AREC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47.73% below the market average47.73% below the market average47.73% below the market average47.73% below the market average47.73% below the market average
13.04% above the sector average13.04% above the sector average13.04% above the sector average13.04% above the sector average13.04% above the sector average
Price Trend
91.58% below the market average91.58% below the market average91.58% below the market average91.58% below the market average91.58% below the market average
69.57% below the sector average69.57% below the sector average69.57% below the sector average69.57% below the sector average69.57% below the sector average
Income Not Available
Growth
42.27% above the market average42.27% above the market average42.27% above the market average42.27% above the market average42.27% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average

AREC Dividends

No dividends found

Trades for 02-Jun-2025

Time Volume / Share Price
11:56 21,177 @ 42.50p
12:02 8,823 @ 42.50p
08:33 556 @ 44.00p
08:13 2,701 @ 42.50p

AREC Key Personnel

CEO Sarah Jennifer Howell
CFO David Ellam

Top of Page